MIRA INFORM REPORT

 

 

Report Date :

27.03.2008

 

 

IDENTIFICATION DETAILS

 

Name :

SRI KRISHNA DRUGS LIMITED

 

 

Registered Office :

C-4, Industrial Area, Uppal, Hyderabad-500039, Andhra Pradesh

 

 

Country :

India

 

 

Financials (as on) :

31.03.2007

 

 

Date of Incorporation :

18.02.1985

 

 

Com. Reg. No.:

01-5315

 

 

CIN No.:

[Company Identification No.]

L24110AP1985PLC005315

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

HYDS00020G

 

 

Legal Form :

A closely held public limited liability company.

 

 

Line of Business :

Manufacturer, Importer, Exporter, Purchaser, Seller and Dealer of all kinds of chemicals inorganic, organic all kinds of drugs.

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 510000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow

 

 

Litigation :

Clear

 

 

Comments :

Subject is an old and established company having moderate track. Company’s profitability is under severe pressure. It continues to incur losses. Payments are reported as slow but correct.

 

The company can be considered normal for small to mediocre business at usual trade terms and conditions. 

 

 

LOCATIONS

 

Registered Office :

C-4, Industrial Area, Uppal, Hyderabad-500039, Andhra Pradesh, India

Tel. No.:

91-40-27201101 / 02 / 03, 27204471 / 72

Fax No.:

91-40-27204470 / 27205432

E-Mail :

skg@gnhyd_skgroup.global.net.in

skg@srikrishnapharma.com

 

 

Factory :

Survey No. 57, Gokuldaham Kalan, Raikunta Building, Shamshabad Mandal Ranga Reddy District-509218, Andhra Pradesh, India

 

 

DIRECTORS

 

Name :

Mr. A. Gangadhar Rao

Designation :

Chairman

Address :

6-3-249/1, Road No. 1, Banjara Hills, Hyderabad – 500034

Date of Appointment :

27.08.1999

 

 

Name :

Dr. V. V. Subba Reddy

Designation :

Managing Director

Address :

3-33-39, Dhanalakshmi Colony, Mahendra, Hills Secunderabad 

Date of Birth/Age :

26.09.1942

Date of Appointment :

18.02.1985

 

 

Name :

Mr. C. Gopala  Krishan Murthy

Designation :

Director

Address :

7-B, Sanjeeva Reddy Nagar, Hyderabad

Date of Appointment :

06.05.1989

 

 

Name :

Mr. V. V. Krishna Reddy

Designation :

Director

Address :

3-33-39, Dhanalakshmi Colony, Mahendra, Hills Secunderabad 

Date of Birth/Age :

31.08.1966

Date of Appointment :

04.06.1998

 

 

Name :

Smt. V Satyavathi

Designation :

Director

Address :

3-33-39, Dhanalakshmi Colony, Mahendra, Hills Secunderabad 

Date of Birth/Age :

18.03.1945

Date of Appointment :

18.02.1985

 

 

Name :

Mr. Y. V. S. S. Murty

Designation :

Director

Address :

Flat No. 2, Prembagh Apartments, 3-4-490/A, Barkatpur, Hyderabad – 500027

Date of Appointment :

29.07.2002

 

 

Name :

Mr. R. R. R. Raju

Designation :

Director

Address :

Flat No. 202, kamalgiri Tower, S – 56 Madhuranagar 3, Hyderaad – 500038

Date of Birth/Age :

12.05.1939

Date of Appointment :

29.07.2005

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 29.09.2005

 

Names of Shareholders

 

No. of Shares

V V Subba Reddy – HUF

 

687190

Sripad Securities Private Limited

 

357900

V V Subba Reddy

 

14500

V Satyavathi

 

649919

V V Krishna Reddy

 

609375

R Sunitha Reddy

 

238648

Siva Kumari

 

10500

R Sunitha Reddy

 

22500

Subashree Investments Private Limited

 

72600

V V Murlinath Reddy

 

11300

 

AS ON 29.09.2007

 

Equity Share Breakup

 

Percentage of Holding

Category

 

 

Bodies corporate

 

14.40

Directors or relatives of directors

 

75.64

Other top fifty shareholders

 

4.00

Other

 

5.96

Total

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer, Importer, Exporter, Purchaser, Seller and Dealer of all kinds of chemicals inorganic, organic all kinds of drugs.

 

 

Products :

Product Description

ITC Code No

Folic Acid

293629.02

Enalapril Maleate

294200.29

 

 

GENERAL INFORMATION

 

No. of Employees :

About 120

 

 

Bankers :

Canara Bank, Overseas Branch, Damayanti, Chambers, Adarshnagar, Hyderabad, Andhra Pradesh, India

 

 

 

Banking Relations :

Satisfactory

 

 

Auditors :

 

Name :

L. B. Reddy and Company

Chartered Accountants

Address :

310, Emerald Apartments, H No. 6-3-713, Amruta Hills, Punjagutta, Hyderabad-500082, Andhra Pradesh, India

 

 

Associates/Subsidiaries :

  • S. K. Group Companies

 

  • Ensolvia Infotech Limited

             CIN No.: U72200AP2000PTC034518

 

 

CAPITAL STRUCTURE

 

Authorised Capital :

No. of Shares

Type

Value

Amount

6000000

Equity shares

Rs. 10/- each

Rs. 60.000 millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

3500000

Equity shares

Rs. 10/- each

Rs. 35.000 millions

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2007

31.03.2006

31.03.2005

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

35.000

35.000

35.000

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

93.318

126.682

138.168

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

128.318

161.682

173.168

LOAN FUNDS

 

 

 

1] Secured Loans

142.911

163.596

119.897

2] Unsecured Loans

45.915

18.352

5.867

TOTAL BORROWING

188.826

181.948

125.764

DEFERRED TAX LIABILITIES

0.000

7.933

10.858

 

 

 

 

TOTAL

317.144

351.563

309.790

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

128.928

129.055

71.952

Capital work-in-progress

0.000

14.819

16.447

 

 

 

 

INVESTMENT

28.773

28.773

28.481

DEFERREX TAX ASSETS

0.470

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

76.556

77.369

45.814

 

Sundry Debtors

68.959

77.138

59.622

 

Cash & Bank Balances

10.220

2.221

1.519

 

Other Current Assets

0.000

0.000

0.000

 

Loans & Advances

52.825

44.739

127.373

Total Current Assets

208.560

201.467

234.328

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Current Liabilities

75.251

57.784

32.666

 

Provisions

7.779

9.358

8.752

Total Current Liabilities

83.030

67.142

41.418

Net Current Assets

125.530

134.325

192.910

 

 

 

 

MISCELLANEOUS EXPENSES

33.443

44.591

0.000

 

 

 

 

TOTAL

317.144

351.563

309.790

 


PROFIT & LOSS ACCOUNT

 

PARTICULARS

 

31.03.2007

31.03.2006

31.03.2005

Sales Turnover

276.005

297.307

163.168

Other Income

16.531

23.847

7.839

Total Income

292.536

321.154

171.007

 

 

 

 

Profit/(Loss) Before Tax

[34.419]

[6.218]

7.115

Provision for Taxation

[29.269]

[7.495]

2.024

Profit/(Loss) After Tax

[5.150]

1.277

5.091

 

 

 

 

Expenditures :

 

 

 

 

Raw Material Consumed

150.206

162.450

94.800

 

Increase/(Decrease) in Finished Goods

2.328

6.479

[5.491]

 

Salaries, Wages, Bonus, etc.

33.373

28.536

12.853

 

Managerial Remuneration

2.414

2.703

2.414

 

Payment to Auditors

0.084

0.056

0.033

 

Interest

15.596

15.366

6.294

 

Insurance Expenses

2.475

2.340

1.751

 

Power & Fuel

28.121

23.203

15.367

 

Depreciation & Amortization

18.595

16.587

9.430

 

Other Expenditure

73.762

69.653

26.441

Total Expenditure

326.954

327.373

163.892

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2007

31.03.2006

31.03.2005

PAT / Total Income

(%)

[1.76]

0.40

2.98

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

[12.47]

[2.09]

4.36

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

[10.20]

[1.88]

2.32

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

[0.27]

[0.04]

0.04

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

2.12

1.54

0.97

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

2.51

3.00

5.66

 

 

LOCAL AGENCY FURTHER INFORMATION

 

BUSINESS

 

Subject is engaged in as Manufacturer, Importer, Exporter, Purchaser, Seller and Dealer of all kinds of chemicals inorganic, organic all kinds of drugs including Vitamin and Malarial, Anti Bacterials, Anti Fungals, Anti Leprotics, Anti Asthmatics, Anti Spasmodics, Anti Amoebics, Anti Pyretics, Anti Cancer, Anti Tubercular, Anti Gout, Anaesthetics, Diuretics, Tranquillisers and Haematinics along with pharmaceutical Formulations based on the aforesaid drugs either in the form of Powder, Tablets, Capsules, Injectables, Liquid or Otherwise.

 

 

 

Bankers Charges Report as per Registry

 

 

Name of the company

SRI KRISHNA DRUGS LIMITED

Presented By

Dr. V. V. Subba Reddy, Managing Director

1) Date and description of instrument creating the change

8th July 1996

Hypothecation of agreement for packing credit

Hypothecation of agreement for cash credit

2) Amount secured by the charge/amount owing on the securities of charge

Rs. 9.000 Millions as sublimit under OCC

Rs. 10 Millions

3) Short particular of the property charged. If the property acquired is subject to charge, date of the acquired of the property should be given

Stock of Raw Materials, Work In Progress, Finished Goods, Stores and Spares and such other goods belonging to the borrower.  

4) Gist of the terms and conditions and extent and operation of the charge.

Interest @ 21 % p.a. or as stipulated by RBI / Canara Bank from time to time

5) Name and Address and description of the person entitled to the charge.

Canara Bank

Overseas Branch, Hyderabad

6) Date  and brief description of instrument modifying the charge

Agreement of Collateral security dated 11.10.2004

Sanction letter dated 11.10.2004 issued by Canara Bank to Ensolvia Limited enhancing the overdraft facility from Rs. 1.600 Millions to Rs. 4.750 Millions 

7) Particulars of modifications specifying the terms and conditions or the extent of operations of the charge in which modification is made and the details of the modification.

Collateral security to Ensolvia Infotech Limited also extended to the enhanced overdraft facility form Rs. 1.600 Millions to Rs. 4.750 Millions on the existing terms and conditions thereby enhancing the overall limits of the company from Rs. 128.118 Millions to Rs. 131.268 Millions

 

Additional security : Plant and Machinery valued at Rs. 64.600 Millions held at Raikunta Village excluding vehicles as at 31.03.2004

 

 

This form is for

Modification of charge

Charge identification number of the modified 

90135593

Corporate identity number of the company

L24110AP1985PLC005315

Name of the company

SRI KRISHNA DRUGS LIMITED

Address of the registered office or of the principal place of  business in India of the company

C-4, Industrial Area, Uppal, Hyderabad-500039, Andhra Pradesh

Type of charge

Immovable Property

Book Debts 

Movable Property

Particular of charge holder

Canara Bank, Overseas Branch, Damayanti, Chambers, Adarshnagar, Hyderabad - 500063, Andhra Pradesh, India

Hyd1983@canbank.co.in

Nature of description of the instrument creating or modifying the charge

Supplemental common hypothecation agreement

Link letter of enhancement of credit facilities

Date of instrument Creating the charge

26.07.2007

Amount secured by the charge

Rs. 17.500 Millions

Brief particulars of the principal terms an conditions and extent and operation of the charge

Rate of Interest

10 %

 

Extent and Operation of the charge

Discount of Export Bills

Short particulars of the property charged

First charge on the stocks and book debts of the company

Charge on fixed assets of the company

Collateral security on land and building and plant and machinery at St. No. 57, Raikunta Village, Samshabad Mandal, Medak [Dist], Andhra Pradesh and at IDA Bollaram Village, Jinnaram Mandal, Medam, A.P.

 

Collateral security of Plot No. 18.464 sq. mts. TS/RS No. 64 Serilingampally Village, Ranagareddy Dist.  

Particulars of the present modification 

Overall credit facilities is enhanced from 216.500 Millions to 234.000 millions

 

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.40.14

UK Pound

1

Rs.80.41

Euro

1

Rs.62.59

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

6

OPERATING SCALE

1~10

3

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

-

--LIQUIDITY

1~10

6

--LEVERAGE

1~10

6

--RESERVES

1~10

5

--CREDIT LINES

1~10

4

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

41

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions